Results
|
1.
|
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). MedStar authors:
Year: 2012
Citation: - American Journal of Cardiology. 110(3):350-5, 2012 Aug 1.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bach RG, Caputo RP, Cohen DJ, Dhar G, Goel A, Gordon P, Kleiman NS, Lopez JJ, Pencina M, Tolerico P, Waksman R, Yen CH
|
|
2.
|
|
|
3.
|
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial. MedStar authors:
- Loh, Joshua P
- Torguson, Rebecca
- Waksman, Ron
Year: 2013
Citation: - Eurointervention. 9(5):613-9, 2013 Sep.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
All authors: - Loh JP, Malik FT, Rodriguez AE, Serra A, Stahnke S, Torguson R, von Strandmann RP, Waksman R
|
|
4.
|
A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease. MedStar authors:
- Bernardo, Nelson L
- Case, Brian
- Craig, Paige E
- Forrestal, Brian
- Waksman, Ron
- Yerasi, Charan
- Zhang, Cheng
Year: 2021
Citation: - Cardiovascular Revascularization Medicine. 33:49-54, 2021 12.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Interventional Cardiology Fellowship
Medline publication type:
All authors: - Bernardo NL, Case BC, Craig PE, Forrestal BJ, Torguson R, Waksman R, Yerasi C, Zhang C
|
|
5.
|
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. MedStar authors:
- Loh, Joshua P
- Torguson, Rebecca
- Waksman, Ron
Citation: - Cardiovascular Revascularization Medicine. 15(1):23-8, 2014 Jan.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
All authors: - Loh JP, Sangiorgi G, Silber S, Stahnke S, Stella PR, Torguson R, von Strandmann RP, Waksman R
|
|
6.
|
Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. MedStar authors:
Year: 2012
Citation: - Journal of Cardiovascular Translational Research . 5(3):366-74, 2012 Jun.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Brown BO, Elashoff MR, Ellis SG, Kraus WE, Lansky AJ, Lieu HD, McPherson JA, PREDICT Investigators, Rosenberg S, Schwartz RS, Topol EJ, Voros S, Waksman R
|
|
7.
|
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III). MedStar authors:
- Dvir, Danny
- Swymelar, Stacy
- Torguson, Rebecca
- Waksman, Ron
- Xue, Zhenyi
Year: 2013
Citation: - Journal of Interventional Cardiology. 26(2):107-13, 2013 Apr.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Bertrand O, Driesman M, Dvir D, Gruberg L, Mehta S, Rossi J, Swymelar S, Torguson R, Waksman R, Xue Z
|